The Clinical Impact of Ganciclovir Prophylaxis on the Occurrence of Bacteremia in Orthotopic Liver Transplant Recipients | Zendy

L. Silvia MunozPrice | Zendy; Malcolm Slifkin | Zendy; Robin Ruthazer | Zendy; Debra D. Poutsiaka | Zendy; Susan Hadley | Zendy; Richard B. Freeman | Zendy; Richard Rohrer | Zendy; Michael Angelis | Zendy; Jeffrey T. Cooper | Zendy; R. Fairchild | Zendy; L. Barefoot | Zendy; Julie R. Bloom | Zendy; Susan Fitzmaurice | Zendy; David R. Snydman | Zendy

Open Access

The Clinical Impact of Ganciclovir Prophylaxis on the Occurrence of Bacteremia in Orthotopic Liver Transplant Recipients

Author(s) -

L. Silvia MunozPrice,

Malcolm Slifkin,

Robin Ruthazer,

Debra D. Poutsiaka,

Susan Hadley,

Richard B. Freeman,

Richard Rohrer,

Michael Angelis,

Jeffrey T. Cooper,

R. Fairchild,

L. Barefoot,

Julie R. Bloom,

Susan Fitzmaurice,

David R. Snydman

Publication year - 2004

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/425002

Subject(s) - bacteremia , medicine , ganciclovir , immunosuppression , liver transplantation , chemoprophylaxis , gastroenterology , confidence interval , hazard ratio , univariate analysis , surgery , transplantation , antibiotics , immunology , multivariate analysis , human cytomegalovirus , virus , microbiology and biotechnology , biology

Cytomegalovirus (CMV) infection or receipt of a CMV-seropositive donor liver has been shown to be an independent predictor of bacteremia in orthotopic liver transplant (OLT) recipients. However, prevention of CMV infection through use of intense CMV prophylaxis has not been examined to assess the impact on bacteremia in liver transplant recipients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research